EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging therapies and future directions in chronic lymphocytic leukaemia - chemotherapy

B D Cheson

Hematology and Cell Therapy · 2000

DOI: 10.1007/s00282-000-0041-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematology and Cell Therapy, 2000. Verfasst von B D Cheson. Beteiligte Einrichtung: Clinical Investigations Branch, National Cancer Institute, Bethesda, MD 20892-7436, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiogenesis InhibitorsAntineoplastic Combined Chemotherapy ProtocolsDrug DesignForecastingGrowth SubstancesHumansLeukemia, Lymphocytic, Chronic, B-CellOrganoplatinum CompoundsOxaliplatin

Substanzen

Angiogenesis InhibitorsGrowth SubstancesOrganoplatinum CompoundsOxaliplatin

Autor:innen und Institutionen

  • Clinical Investigations Branch, National Cancer Institute, Bethesda, MD 20892-7436, USA.

Zitieren

APA

Cheson, B. D. (2000). Emerging therapies and future directions in chronic lymphocytic leukaemia - chemotherapy. Hematology and Cell Therapy. https://doi.org/10.1007/s00282-000-0041-0

Vancouver

Cheson BD. Emerging therapies and future directions in chronic lymphocytic leukaemia - chemotherapy. Hematology and Cell Therapy. 2000. doi:10.1007/s00282-000-0041-0

BibTeX
@article{Cheson2000,
  author = {Cheson, B D},
  title = {Emerging therapies and future directions in chronic lymphocytic leukaemia - chemotherapy},
  journal = {Hematology and Cell Therapy},
  year = {2000},
  doi = {10.1007/s00282-000-0041-0}
}
Kostenlos starten →